Literature DB >> 19862842

Mutation spectrum of homogentisic acid oxidase (HGD) in alkaptonuria.

Thierry Vilboux1, Michael Kayser, Wendy Introne, Pim Suwannarat, Isa Bernardini, Roxanne Fischer, Kevin O'Brien, Robert Kleta, Marjan Huizing, William A Gahl.   

Abstract

Alkaptonuria (AKU) is a rare autosomal recessive metabolic disorder, characterized by accumulation of homogentisic acid, leading to darkened urine, pigmentation of connective tissue (ochronosis), joint and spine arthritis, and destruction of cardiac valves. AKU is due to mutations in the homogentisate dioxygenase gene (HGD) that converts homogentisic acid to maleylacetoacetic acid in the tyrosine catabolic pathway. Here we report a comprehensive mutation analysis of 93 patients enrolled in our study, as well as an extensive update of all previously published HGD mutations associated with AKU. Within our patient cohort, we identified 52 HGD variants, of which 22 were novel. This yields a total of 91 identified HGD variations associated with AKU to date, including 62 missense, 13 splice site, 10 frameshift, 5 nonsense, and 1 no-stop mutation. Most HGD variants reside in exons 3, 6, 8, and 13. We assessed the potential effect of all missense variations on protein function, using five bioinformatic tools specifically designed for interpretation of missense variants (SIFT, POLYPHEN, PANTHER, PMUT, and SNAP). We also analyzed the potential effect of splice-site variants using two different tools (BDGP and NetGene2). This study provides valuable resources for molecular analysis of alkaptonuria and expands our knowledge of the molecular basis of this disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19862842      PMCID: PMC2830005          DOI: 10.1002/humu.21120

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  54 in total

1.  The genetic defect of the alkaptonuric mouse (aku).

Authors:  W Kress; S R Schmidt; B Halliger-Keller; X Montagutelli; C R Müller
Journal:  Mamm Genome       Date:  1999-01       Impact factor: 2.957

2.  Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies--a case study of 14 patients in 11 families.

Authors:  Aicha Ladjouze-Rezig; Santiago Rodriguez de Cordoba; Robert Aquaron
Journal:  Joint Bone Spine       Date:  2005-07-07       Impact factor: 4.929

3.  Oxidation of homogentisic acid to ochronotic pigment in connective tissue.

Authors:  V G Zannoni; N Lomtevas; S Goldfinger
Journal:  Biochim Biophys Acta       Date:  1969-02-18

4.  [Analysis of the life span of alkaptonuric patients].

Authors:  S Srsen; J Vondrácek; K Srsnová; J Svác
Journal:  Cas Lek Cesk       Date:  1985-10-18

5.  The molecular basis of alkaptonuria.

Authors:  J M Fernández-Cañón; B Granadino; D Beltrán-Valero de Bernabé; M Renedo; E Fernández-Ruiz; M A Peñalva; S Rodríguez de Córdoba
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

6.  A novel therapeutic trial of homogentisic aciduria in a murine model of alkaptonuria.

Authors:  Y Suzuki; K Oda; Y Yoshikawa; Y Maeda; T Suzuki
Journal:  J Hum Genet       Date:  1999       Impact factor: 3.172

7.  Molecular defects in alkaptonuria.

Authors:  A Gehrig; S R Schmidt; C R Müller; S Srsen; K Srsnova; W Kress
Journal:  Cytogenet Cell Genet       Date:  1997

8.  Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information.

Authors:  S M Hebsgaard; P G Korning; N Tolstrup; J Engelbrecht; P Rouzé; S Brunak
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

Review 9.  Alkaptonuria in Slovakia: thirty-two years of research on phenotype and genotype.

Authors:  Stefan Srsen; Clemens R Müller; Andreas Fregin; Klara Srsnova
Journal:  Mol Genet Metab       Date:  2002-04       Impact factor: 4.797

10.  SNAP: predict effect of non-synonymous polymorphisms on function.

Authors:  Yana Bromberg; Burkhard Rost
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

View more
  22 in total

1.  Identification of 11 Novel Homogentisate 1,2 Dioxygenase Variants in Alkaptonuria Patients and Establishment of a Novel LOVD-Based HGD Mutation Database.

Authors:  Andrea Zatkova; Tatiana Sedlackova; Jan Radvansky; Helena Polakova; Martina Nemethova; Robert Aquaron; Ismail Dursun; Jeannette L Usher; Ludevit Kadasi
Journal:  JIMD Rep       Date:  2011-10-20

2.  An update on molecular genetics of Alkaptonuria (AKU).

Authors:  Andrea Zatkova
Journal:  J Inherit Metab Dis       Date:  2011-07-01       Impact factor: 4.982

3.  Analysis of HGD Gene Mutations in Patients with Alkaptonuria from the United Kingdom: Identification of Novel Mutations.

Authors:  Jeannette L Usher; David B Ascher; Douglas E V Pires; Anna M Milan; Tom L Blundell; Lakshminarayan R Ranganath
Journal:  JIMD Rep       Date:  2015-02-15

4.  Identification of alkaptonuria in the general population: a United Kingdom experience describing the challenges, possible solutions and persistent barriers.

Authors:  L Ranganath; A M Taylor; A Shenkin; W D Fraser; J Jarvis; J A Gallagher; N Sireau
Journal:  J Inherit Metab Dis       Date:  2011-02-11       Impact factor: 4.982

5.  A Founder Effect for the HGD G360R Mutation in Italy: Implications for a Regional Screening of Alkaptonuria.

Authors:  Berardino Porfirio; Roberta Sestini; Greta Gorelli; Miriam Cordovana; Alessandro Mannoni; Jeanette L Usher; Wendy J Introne; William A Gahl; Thierry Vilboux
Journal:  JIMD Rep       Date:  2016-03-10

6.  [Osteoarthritis in hereditary metabolic diseases].

Authors:  J Zwerina; T Dallos
Journal:  Orthopade       Date:  2010-06       Impact factor: 1.087

7.  Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in Italy.

Authors:  Martina Nemethova; Jan Radvanszky; Ludevit Kadasi; David B Ascher; Douglas E V Pires; Tom L Blundell; Berardino Porfirio; Alessandro Mannoni; Annalisa Santucci; Lia Milucci; Silvia Sestini; Gianfranco Biolcati; Fiammetta Sorge; Caterina Aurizi; Robert Aquaron; Mohammed Alsbou; Charles Marques Lourenço; Kanakasabapathi Ramadevi; Lakshminarayan R Ranganath; James A Gallagher; Christa van Kan; Anthony K Hall; Birgitta Olsson; Nicolas Sireau; Hana Ayoob; Oliver G Timmis; Kim-Hanh Le Quan Sang; Federica Genovese; Richard Imrich; Jozef Rovensky; Rangan Srinivasaraghavan; Shruthi K Bharadwaj; Ronen Spiegel; Andrea Zatkova
Journal:  Eur J Hum Genet       Date:  2015-03-25       Impact factor: 4.246

8.  [Acute bilateral shoulder pain as initial presentation of ochronosis: a case report and literature review].

Authors:  N Laktasic-Zerjavic; B Curkovic; D Babic-Naglic; K Potocki; M Prutki; D Soldo-Juresa
Journal:  Z Rheumatol       Date:  2010-07       Impact factor: 1.372

9.  Neglected Alkaptonuric Patient Presenting with Steppage Gait.

Authors:  Babak Mirzashahi; Abbas Tafakhori; Arvin Najafi; Mahmoud Farzan
Journal:  Arch Bone Jt Surg       Date:  2016-04

Review 10.  Alkaptonuria.

Authors:  Jemma B Mistry; Marwan Bukhari; Adam M Taylor
Journal:  Rare Dis       Date:  2013-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.